Nicotinic Receptor Alpha9 Subunit (CHRNA9)

Migration, Crosslink

📖

Nicotinic Receptor Alpha9 Subunit (CHRNA9)

active

wiki page Created: 2026-04-02T07:19:15 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-proteins-chrna9

📖 Wiki Page

protein972 wordssynced 2026-04-02

Nicotinic Receptor Alpha9 Subunit (CHRNA9)

Introduction

Nicotinic Receptor Alpha9 Subunit (CHRNA9) is an important component of the cholinergic signaling system in the nervous system. This page provides detailed information about its structure, function, and role in neurodegenerative diseases.

<div class="infobox infobox-protein"> [@sgard2002]
<table> [@wonnacott2006]
<tr><th colspan="2" style="background:#e8f4ea;">Nicotinic Receptor Alpha9 Subunit</th></tr> [@vona2015]
<tr><td><b>Protein Name</b></td><td>Nicotinic Receptor Alpha9 Subunit</td></tr> [@wang2003]
<tr><td><b>Gene</b></td><td>[CHRNA9](/genes/chrna9)</td></tr> [@quik2015]
<tr><td><b>UniProt ID</b></td><td>[Q9GZZ3](https://www.uniprot.org/uniprot/Q9GZZ3)</td></tr> [@kabbani2013]
<tr><td><b>Molecular Weight</b></td><td>55.6 kDa</td></tr> [@bordia2015]
<tr><td><b>Subcellular Localization</b></td><td>Plasma membrane (ion channel)</td></tr> [@wang2014]
<tr><td><b>Protein Family</b></td><td>Cys-loop nicotinic [acetylcholine](/entities/acetylcholine) receptor family</td></tr> [@dineley2015]
<tr><td><b>Associated Diseases</b></td><td>Auditory neuropathy, Parkinson's Disease, Schizophrenia</td></tr> [@leonard2002]
</table> [@gilman2008]
</div> [@mallenpedersen2015]

Overview

...

Nicotinic Receptor Alpha9 Subunit (CHRNA9)

Introduction

Nicotinic Receptor Alpha9 Subunit (CHRNA9) is an important component of the cholinergic signaling system in the nervous system. This page provides detailed information about its structure, function, and role in neurodegenerative diseases.

<div class="infobox infobox-protein"> [@sgard2002]
<table> [@wonnacott2006]
<tr><th colspan="2" style="background:#e8f4ea;">Nicotinic Receptor Alpha9 Subunit</th></tr> [@vona2015]
<tr><td><b>Protein Name</b></td><td>Nicotinic Receptor Alpha9 Subunit</td></tr> [@wang2003]
<tr><td><b>Gene</b></td><td>[CHRNA9](/genes/chrna9)</td></tr> [@quik2015]
<tr><td><b>UniProt ID</b></td><td>[Q9GZZ3](https://www.uniprot.org/uniprot/Q9GZZ3)</td></tr> [@kabbani2013]
<tr><td><b>Molecular Weight</b></td><td>55.6 kDa</td></tr> [@bordia2015]
<tr><td><b>Subcellular Localization</b></td><td>Plasma membrane (ion channel)</td></tr> [@wang2014]
<tr><td><b>Protein Family</b></td><td>Cys-loop nicotinic [acetylcholine](/entities/acetylcholine) receptor family</td></tr> [@dineley2015]
<tr><td><b>Associated Diseases</b></td><td>Auditory neuropathy, Parkinson's Disease, Schizophrenia</td></tr> [@leonard2002]
</table> [@gilman2008]
</div> [@mallenpedersen2015]

Overview

The alpha9 subunit forms nicotinic acetylcholine receptors (nAChRs) with the alpha10 subunit, creating receptors sensitive to acetylcholine and ototoxic compounds. CHRNA9 is unique among neuronal nAChRs as it can form functional receptors with alpha10 or as homomeric channels[@elgoyhen2001]. [@vincler2006]

Structure

The CHRNA9 protein belongs to the Cys-loop nicotinic acetylcholine receptor family, which includes ligand-gated ion channels composed of five subunits. Each subunit contains:

Extracellular N-terminal domain: Contains the characteristic Cys-loop motif and agonist binding sites
Transmembrane domains (M1-M4): Form the ion channel pore
Intracellular loop: Contains sites for post-translational modifications and protein interactions
C-terminal domain: Involved in receptor assembly and trafficking

The receptor typically forms as an α9α10 heteromeric assembly, although homomeric α9 receptors can also function[@sgard2002].

| Attribute | Value |
|-----------|-------|
| Gene | [CHRNA9](/proteins/chrna9-protein) |
| UniProt | [Q9GZZ3](https://www.uniprot.org/uniprot/Q9GZZ3) |
| Protein Family | Cys-loop nAChR family |
| Ion Selectivity | Calcium, Sodium, Potassium |
| Channel Type | Ligand-gated cation channel |

Normal Function in the Nervous System

CHRNA9-containing nAChRs play diverse roles in the nervous system:

Cholinergic Signaling

Mediates fast synaptic transmission at cholinergic synapses
Modulates neurotransmitter release including glutamate, GABA, and dopamine[@wonnacott2006]
Participates in feedback regulation of acetylcholine release

Auditory System

Essential for normal hearing function
Expressed in outer hair cells of the cochlea
Mutations cause auditory neuropathy spectrum disorder (ANSD)[@vona2015]

Neuroimmune Modulation

Expressed in immune cells including macrophages and T lymphocytes
Regulates cytokine production and inflammatory responses
Alpha7 and alpha9 nAChRs mediate the "cholinergic anti-inflammatory pathway"[@wang2003]

Sensory Processing

Involved in pain modulation via peripheral nerve fibers
Contributes to vestibular function and balance

Role in Neurodegenerative Diseases

Parkinson's Disease

CHRNA9 plays a significant role in Parkinson's disease pathophysiology:

Dopaminergic neuron protection: α9* nAChRs on substantia nigra dopamine [neurons](/entities/neurons) provide neuroprotective signaling[@quik2015]
Neuroinflammation: Cholinergic modulation of [microglia](/entities/microglia) via α9 receptors influences neuroinflammatory processes in PD[@kabbani2013]
Levodopa-induced dyskinesia: α9* nAChR agonists reduce dyskinesia severity in preclinical PD models[@bordia2015]
Genetic associations: CHRNA9 polymorphisms have been linked to PD susceptibility in some populations[@wang2014]

Alzheimer's Disease

Cholinergic deficits in AD involve dysfunction of multiple nAChR subtypes
α9* nAChRs regulate [amyloid-beta](/proteins/amyloid-beta) induced neurotoxicity[@dineley2015]
Targeting α9* nAChRs may enhance cognitive function in AD

Schizophrenia

CHRNA9 expression is altered in schizophrenic brain tissue
The receptor may be a therapeutic target for cognitive deficits[@leonard2002]
Genetic variants in CHRNA9 associated with schizophrenia risk

Multiple System Atrophy (MSA)

Dysregulated α9 nAChR signaling contributes to autonomic dysfunction in MSA[@gilman2008]
The receptor influences cardiovascular control via autonomic ganglia

Molecular Mechanisms

Ion Channel Function

CHRNA9-containing nAChRs are permeable to Na+, K+, and Ca2+. The Ca2+ permeability is particularly important for:

Triggering intracellular signaling cascades
Modulating neurotransmitter release
Regulating gene expression

Protein-Protein Interactions

| Interactor | Interaction Type | Functional Significance |
|------------|-----------------|----------------------|
| CHRNA10 | Heteromeric assembly | Functional receptor formation |
| RIC-3 | Chaperone | Receptor assembly and trafficking |
| Lynx1 | Modulatory binding | Receptor desensitization regulation |
| PICK1 | PDZ domain | Synaptic localization |
| PSD-95 | Scaffold | Postsynaptic density organization |

Signaling Pathways

Acetylcholine binding
↓
CHRNA9 receptor activation
↓
Ca2+ influx → Calmodulin activation
↓
PKC / CaMKII / Calcineurin activation
↓
Gene transcription / Neuroprotection

Therapeutic Targeting

Drug Development

α9* nAChR agonists:

Nicotine (non-selective)
PnTX (π-asaro-toxin)
Selective agonists in development for neuroprotection[@mallenpedersen2015]

α9* nAChR antagonists:

α-Conotoxin RgIA
Used for hearing protection and pain management[@vincler2006]

Positive allosteric modulators (PAMs):

Enhancement of receptor function for therapeutic benefit

Clinical Applications

Parkinson's disease: α9* nAChR agonists as disease-modifying agents
Hearing disorders: Gene therapy for CHRNA9 mutations
Neuropathic pain: α9* nAChR antagonists
Cognitive enhancement: CHRNA9 modulation in AD

Research Directions

Developing subtype-selective ligands with better pharmacokinetics
Understanding CHRNA9 polymorphisms and disease susceptibility
iPSC models from PD patients with CHRNA9 variants
Gene therapy approaches for auditory neuropathy

Background

The study of Nicotinic Receptor Alpha9 Subunit (CHRNA9) has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

External Links

[UniProt](https://www.uniprot.org/uniprot/Q9GZZ3)
[NCBI Protein](https://www.ncbi.nlm.nih.gov/protein)
[Ensembl](https://www.ensembl.org)
[PDB](https://www.rcsb.org/)
[GeneCards](https://www.genecards.org/cgi-bin/carddisp.pl?gene=CHRNA9)

References

[Elgoyhen AB, et al, (2001) (2001)](https://pubmed.ncbi.nlm.nih.gov/11438697/)

[Sgard F, et al, (2002) (2002)](https://pubmed.ncbi.nlm.nih.gov/11901227/)

[Wonnacott S, et al, (2006) (2006)](https://pubmed.ncbi.nlm.nih.gov/16324766/)

[Vona B, et al, (2015) (2015)](https://pubmed.ncbi.nlm.nih.gov/25735521/)

[Wang H, et al, (2003) (2003)](https://pubmed.ncbi.nlm.nih.gov/12818166/)

[Quik M, et al, (2015) (2015)](https://pubmed.ncbi.nlm.nih.gov/25744942/)

[Kabbani N, et al, (2013) (2013)](https://pubmed.ncbi.nlm.nih.gov/24085854/)

[Bordia T, et al, (2015) (2015)](https://pubmed.ncbi.nlm.nih.gov/25817353/)

[Wang J, et al, (2014) (2014)](https://pubmed.ncbi.nlm.nih.gov/24893167/)

[Dineley KT, et al, (2015) (2015)](https://pubmed.ncbi.nlm.nih.gov/25676554/)

[Leonard S, et al, (2002) (2002)](https://pubmed.ncbi.nlm.nih.gov/12684091/)

[Gilman S, et al, (2008) (2008)](https://pubmed.ncbi.nlm.nih.gov/18570215/)

[Mallen-Pedersen M, et al, (2015) (2015)](https://pubmed.ncbi.nlm.nih.gov/26177806/)

[Vincler M, et al, (2006) (2006)](https://pubmed.ncbi.nlm.nih.gov/16477120/)

📖 View canonical wiki page →

Related Entities

CHRNA9

▸Metadataorigin_type: v1_polymorphic_backfill

slug	proteins-chrna9
kg_node_id	CHRNA9
entity_type	protein
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-41a118abd95a
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'proteins-chrna9'}
_schema_version	1

📊 Evidence Profile

Evidence Balance

+0%

Certainty

40%

Debates

0

Incoming

8

Outgoing

9

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

Nicotinic Receptor Alpha9 Subunit (CHRNA9)

Nicotinic Receptor Alpha9 Subunit (CHRNA9)

Introduction

Overview

Nicotinic Receptor Alpha9 Subunit (CHRNA9)

Introduction

Overview

Structure

Normal Function in the Nervous System

Cholinergic Signaling

Auditory System

Neuroimmune Modulation

Sensory Processing

Role in Neurodegenerative Diseases

Parkinson's Disease

Alzheimer's Disease

Schizophrenia

Multiple System Atrophy (MSA)

Molecular Mechanisms

Ion Channel Function

Protein-Protein Interactions

Signaling Pathways

Therapeutic Targeting

Drug Development

Clinical Applications

Research Directions

Background

See Also

External Links

References

💬 Discussion